C. diff. Spores and More

Join our guest, Ron Romano, RN as we discuss Infection prevention - the guidelines and recommendations related to a healthcare-associated infection in multiple settings. Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The guidelines and recommendations related to infection prevention. HAIs are currently one of the top ten leading causes of death in the United States. Healthcare professionals have an important role in HAI prevention.

Learning ways to reduce stress and manage time is helpful to the caregiver. People who neglect their own needs and forget to nurture themselves are at danger of falling into fatigue and high stress. There are important basic self care strategies that can keep you functioning well and ready for life's challenges. There are times when people spend their time only taking care of others can be at risk for getting burned out on all the giving, which makes it more difficult to care for others or themselves. Taking time to care for yourself regularly can make you a better caretaker for others. Join us with guests Linda Jablonski, MS,BSN,BC-RN, and Barbara Baker Schaefer, MSW, as we discuss several different ways to focus on self-care, the balance of leisure time in your schedule - making time for yourself, family, and friends.

This episode will provide foundational educational information about the microbiome by answering the fundamental questions of what is it, why is it important, how does it impact patients with C. difficile infections, and what are the possibilities of the microbiome as a therapeutic target for future drugs. This interview will be with Dr. Matthew Henn, Senior Vice President and Head of Drug Discovery & Bioinformatics at Seres Therapeutics, Inc,. Seres Therapeutics is a leading microbiome therapeutics company dedicated to creating a new class of medicines to treat diseases resulting from imbalances in the microbiome. These first-in-class drugs, called Ecobiotics®, are ecological compositions of beneficial organisms that are designed to restore a healthy human microbiome. The discovery efforts at Seres Therapeutics currently span metabolic, inflammatory, and infectious diseases.

Join us as Dr. Ron Daniels, MD and

Dr. Imrana Malik, MD discuss Sepsis. Sepsis, one of the most prevalent but misdiagnosed, deadly diseases, was established as a global priority by the World Health Assembly, the decision-making body of the WHO, in the last week of May. In this episode,

Dr Ron Daniels, Physician, Founder and CEO of the UK Sepsis Trust and Member of the Board of the Global Sepsis Alliance, and Dr Imrana Malik, Associate Professor in the Department of Critical Care at MD Anderson Cancer Center in Houston, TX, and Coordinator of GSA Advance, will explain why the resolution on sepsis is a milestone in the global fight against sepsis and what implications it will have.

Listen in as our guests Dr. Caterina Oneto, MD and Dr. Paul Feuerstadt, MD both specializing in Gastroenterology -- will be discussing IBD and what Inflammatory bowel disease (IBD) involves, including the chronic inflammation of all or part of the digestive tract. The Physicians will also be discussing signs and symptoms and diagnosing of a C. difficile Infection (CDI) along with the preventative measures, treatments available, and environmental safety products that can be utilized in a home setting. If you have any questions for the Physicians, e-mail us before the live broadcast at [email protected] and we will share the answers during the program.

Join us with our guests, Lisa Hurka-Covington, Kathy Bischoff, Renetta Dudinski, and Veronica Edmond all C. diff. Survivors sharing their personal journey and road to recovery from a C. difficile infection. Nothing resonates more than the words shared from an individual who has been diagnosed, treated, and has recovered from this infection and other wellness-draining illnesses. If you have any questions for any of our guests, e-mail them to [email protected] and we look forward to answering them on the live broadcast.

Join us with our guest, Dr. Joseph Sliman, MD, MPH, Chief Medical Officer of Synthetic Biologics as Dr. Sliman discusses the protection of the natural gut microbiome from the unintended consequences of intravenous (IV) antibiotics which are excreted into the gut is expected to protect against opportunistic enteric infections. Synthetic Biologics is developing two microbiome-focused drug candidates in Phase 3 development including, SYN-004 (ribaxamase) which is designed to protect the gut microbiome by degrading certain IV beta-lactam antibiotics for the prevention of Clostridium difficile infection (CDI), pathogenic overgrowth and the emergence of antimicrobial resistance, and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C).

Join our guest, Ron Romano, RN as we discuss Infection prevention - the guidelines and recommendations related to a healthcare-associated infection in multiple settings. Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The guidelines and recommendations related to infection prevention. HAIs are currently one of the top ten leading causes of death in the United States. Healthcare professionals have an important role in HAI prevention.

Join us and our three guests,

Bradley Whitchurch, Founder and Chairman of the Board at Seal Shield, LLC,

Dr. Rosie D. Lyles, MD, Clinical Affairs Head, Research and Department, Clorox Healthcare and

Shelby Lassiter, BSN, RN, CPHQ, CIC, an Infection Preventionist as they come together to discuss

C. diff. infections, hospital-associated infections,

and you will want to know why hand hygiene

alone is not enough, plus infection prevention

measures in the healthcare and home settings.

Join Steven D. Johnson, PA-C who has practiced in Internal Medicine and Geriatric Medicine departments for the last 34 years. Steven will be discussing the care of the senior population and patients in a skilled nursing setting for short-term rehabilitation services. There are many challenges encountered in a Skilled Nursing Setting and Steven will be sharing the experiences and positive goals of care for patients.